Riverstone (AP4) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
11 Sep, 2026Executive summary
Revenue for 3QFY24/3Q2024 surged 33.9% year-over-year to RM298.4 million, driven by higher sales volume, improved product mix, and increased production.
Net profit for 3QFY24/3Q2024 increased 21.8% year-over-year to RM72.2 million, supported by higher value gloves and operational efficiency.
For the nine months ended 30 September 2024, revenue reached RM794.8 million, up 16.1% year-over-year, with net profit at RM216.9 million, a 41.9% increase.
Diversified revenue streams from cleanroom and healthcare businesses, with strong R&D and flexible production.
Maintains a resilient balance sheet, consistent dividend payouts, and a focus on ESG initiatives.
Financial highlights
3QFY24/3Q2024 gross profit rose 33.2% year-over-year to RM103.6 million; gross margin was 34.7%.
9M FY2024 gross profit increased 46.8% year-over-year to RM300.3 million.
Operating profit margin for 3QFY24 was 30.3%, down 2.7 percentage points due to foreign exchange loss.
Earnings per share for 3QFY24/3Q2024 were 4.87 sen, up from 4.00 sen in 3Q2023; 9M2024 EPS was 14.63 sen, up from 10.31 sen in 9M2023.
Cash and cash equivalents stood at RM790.1 million as of 30 September 2024.
Outlook and guidance
Six new cleanroom and three healthcare production lines to be commissioned by end 2024; three more healthcare lines by 1Q2025.
Focus on R&D, flexible production, and ESG to maintain competitive edge and adapt to market changes.
Ongoing initiatives to reduce water, electricity, and waste, and to increase renewable energy usage.
Management expects price competition, currency fluctuations, and cost pressures to persist over the next 12 months.
Latest events from Riverstone
- FY23 declined YoY, but 4Q growth and margin expansion point to recovery.AP4
H2 2023 - FY2022 earnings fell amid normalisation as cleanroom growth became the strategic focus.AP4
H2 2022 - Net profit rose 5.0% year-over-year, with gross margin at 36.0% and a 5.0 sen dividend declared.AP4
H1 2026 - Q4 gains and cleanroom demand temper FY25 declines amid FX and generic-glove pressure.AP4
H2 2025 - Q3 net profit rose sequentially on cleanroom demand, but year-over-year results declined.AP4
Q3 2025 - Net profit dropped 29.6% year-over-year as margin pressure and costs persisted.AP4
H1 2025 - Net profit jumped 54.6% y-o-y to RM144.7m, with gross margin up to 39.6% for 1HFY24.AP4
H1 2024 - Net profit dropped 21.8% year-over-year despite higher revenue and a reduced dividend.AP4
Q1 2025 - FY2024 profit growth and customisation lifted margins; dividends totalled 24 sen per share.AP4
H2 2024